A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data

C. Leissinger, C. Negrier, Erik Berntorp, J. Windyga, M. Serban, A. Bulent, R. Lassila, K. Kavakli, B. Zulfikar, A. Gringeri

Forskningsoutput: TidskriftsbidragPublicerat konferensabstractPeer review

Originalspråkengelska
Sidor (från-till)31-31
TidskriftHaemophilia
Volym16
NummerSuppl. 4
DOI
StatusPublished - 2010
EvenemangXXIXth International Congress of the World Federation of Hemophilia - Buenos Aires, Argentina
Varaktighet: 2010 juli 102010 juli 14

Ämnesklassifikation (UKÄ)

  • Hematologi

Citera det här